This analysis reinforces that discontinuation of anti-obesity medications is frequently followed by significant weight regain, with the magnitude proportional to the initial weight loss effect of the drug
What if the problem is sitting right there in your reconstitution step, hiding in plain sight, costing you potency every single week
Reducing Health Risks: Beyond weight loss, GLP-1 therapies improve metabolic health by supporting blood sugar control, lowering cholesterol, and reducing blood pressure, helping to decrease the risk of obesity-related conditions such as type 2 diabetes and heart disease
What concerns me most is when patients delay treatment for years waiting for a perfect answer that probably doesnt exist, said Terushkin
PLoS ONE 7 , e39656 (2012)